Sherif Louis

Sherif Louis serves as CEO at Telo Genomics. Telo Genomics operates in the research sector with approximately 14.0 employees. The company is headquartered in Toronto, Ontario. Telo Genomics generates annual revenue of 3500000.0.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 3,797 executive contacts are available in Ontario.
• • Our database includes 201,469 c suite-level executives.

Gmail Google Apps Amazon AWS Vimeo WordPress.org Google Font API Mobile Friendly Remote AI IoT SharePoint Flutter Android Python Node.js

biotechnology research telomere technology genomic instability liquid biopsy cancer diagnostics multiple myeloma non-invasive testing predictive modeling prognostic tools alzheimer's disease mrd solutions 3d telomere profiling single cell analysis circulating tumor cells genetic diseases clinical validation biomarker identification actionable insights tumor behavior prediction treatment response clinical trials cancer biomarker diagnostic applications treatment personalization comprehensive testing pathology accreditation proprietary technology biotechnology cancer genomics clinical decision support spatial organization of telomeres disease profiling patient stratification research collaborations molecular diagnostics cutting-edge technology disease monitoring advanced analytics cancer research peer-reviewed publications healthcare solutions therapeutic interventions telomere dysfunction liquid biopsy technology telomere structure analysis telomere aggregates clia certified testing iso accreditation genomic assays diagnostic assays oncology research health care health wellness & fitness hospital & health care

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Sherif Louis in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Telo Genomics.

Sherif Louis's Position in the MessageCEO Database

• •Sherif Louis is 1 of 1 verified executive contact we track at Telo Genomics.
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •3,711 verified executive contacts in Ontario are in the database.
• •4 verified contacts work at research companies in the 14.0 employee range (same size as Telo Genomics).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated June 2026.

How do I reach Sherif Louis directly?

Sherif Louis's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at Telo Genomics. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Sherif Louis work for?

Sherif Louis is CEO at Telo Genomics, a company in the research sector with 14.0 employees. The company is based in Toronto, Ontario.

Can I pitch or sell to Sherif Louis?

As CEO at Telo Genomics, Sherif Louis is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Sherif Louis directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Sherif Louis in?

Sherif Louis works in the research industry as CEO at Telo Genomics. MessageCEO provides verified contact information for executives across all major industries.

Is Sherif Louis's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Sherif Louis's profile is kept up-to-date with the latest available information.

Last updated: June 24, 2026